SC 13D

Company

AEON Biopharma, Inc.

Filed

July 31, 2023

Accession Number

0001477932-23-005629

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →